Mark Wilterding | executive |
Bernard Zovighian | executive |
Scott Ullem | executive |
Robert Marcus | analyst |
Daveen Chopra | executive |
Larry Wood | executive |
Travis Steed | analyst |
Larry Biegelsen | analyst |
Matthew Taylor | analyst |
Joanne Wuensch | analyst |
Katie Szyman | executive |
Matthew Miksic | analyst |
Shagun Singh Chadha | analyst |
Christopher Pasquale | analyst |
Pito Chickering | analyst |
Richard Newitter | analyst |
Danielle Antalffy | analyst |
Joshua Jennings | analyst |
Greetings, and welcome to the Edwards Lifesciences first quarter 2024 results. [Operator Instructions].
As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Mark Wilterding, Senior Vice President, Investor Relations. Thank you, you may begin.